NIAGEN BIOSCIENCE, INC. (NAGE)

3.17USD +1.93% (+0.06)

Over 1M: +1.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

3 3.1 3.2 3.3
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 19.5M Q3 '23 — Operating Income: -1.1M Q3 '23 — Operating Cash Flow: 396K Q4 '23 — Revenue: 21.2M Q4 '23 — Operating Income: -168K Q4 '23 — Operating Cash Flow: 649K Q1 '24 — Revenue: 22.2M Q1 '24 — Operating Income: -731K Q1 '24 — Operating Cash Flow: 295K Q2 '24 — Revenue: 22.7M Q2 '24 — Operating Income: -256K Q2 '24 — Operating Cash Flow: -264K Q3 '24 — Revenue: 25.6M Q3 '24 — Operating Income: 1.6M Q3 '24 — Operating Cash Flow: 3.5M Q4 '24 — Revenue: 29.1M Q4 '24 — Operating Income: 7.1M Q4 '24 — Operating Cash Flow: 8.6M Q1 '25 — Revenue: 30.5M Q1 '25 — Operating Income: 4.8M Q1 '25 — Operating Cash Flow: 7.9M Q2 '25 — Revenue: 31.1M Q2 '25 — Operating Income: 3.2M Q2 '25 — Operating Cash Flow: 1.2M Q3 '25 — Revenue: 34M Q3 '25 — Operating Income: 4.2M Q3 '25 — Operating Cash Flow: 3.7M Q4 '25 — Revenue: 33.8M Q4 '25 — Operating Income: 4.1M Q4 '25 — Operating Cash Flow: 679K Q1 '26 — Revenue: 31.5M Q1 '26 — Operating Income: 1.6M Q1 '26 — Operating Cash Flow: -1.2M Q2 '26 — Revenue: 29.8M Q2 '26 — Operating Income: 700K Q2 '26 — Operating Cash Flow: 2.8M 0 8M 16M 24M 32M 40M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Income Operating Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.1
ROIC 53.0%
OE margin -0.77%
ROA 15.0%
Gross margin 64.2%
ROCE 11.6%
ROE 19.4%
Accruals 9.4%
FCF margin 4.6%
OCF margin 4.6%
OCF / EBIT 0.56×
Capex / sales —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

4.6
EV/EBIT 17.1×
EV/OE -182.4×
EV/GP 2.2×
EV/Sales 1.4×
P/C 3.7×
P/E 15.5×
FCF yield 2.4%
P/B 3.0×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.8
Segment HHI 0.38 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

10.0
Interest cover 10598.0×
ND/EBITDA 0.37
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 5.1×
F-score 5.6 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.9
Sales CAGR 4Y +17.7%
Sales/sh Y/Y +1.5%
EPS Y/Y -17.5%
EBIT Y/Y -36.4%
Sales Q/Q -4.3%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.